Aim We studied real‐world performance of MiniMed (MM) 780G system users from
Argentina, Brazil, Colombia and Chile (geographical analysis), and the effect of each …

Introduction: The present report celebrates the benchmarking of 100,000 MiniMed™ 780G
system users in Europe, Middle East, and Africa (EMEA) and summarizes the major insights …

Background: The MiniMed™ 780G system includes an advanced hybrid closed loop (AHCL)
algorithm that provides both automated basal and correction bolus insulin delivery. The …

Introduction The advanced hybrid closed loop (AHCL) MiniMed™ 780G system changes
basal insulin delivery every 5 min and auto bolus in response to sensor glucose values. We …

Aim Automated insulin delivery systems have improved glycaemic control in people with
type 1 diabetes mellitus. The analysis investigated predictors of improved sensor glucose …

Background: We analyzed real-world evidence to assess the performance of the mylife
CamAPS FX hybrid closed-loop system. Methods: Users from 15 countries across different …

Background: The Medtronic MiniMed™ 670G system adjusts basal insulin delivery in
response to continuous glucose monitoring levels and is already in use in clinical practice …

Hybrid closed‐loop systems are characterized by the coexistence of algorithm‐driven
automated insulin delivery combined with manual mealtime boluses. Used correctly, these …

Objective: Intensive glucose management with insulin pump and continuous glucose
monitoring therapy in insulin-treated patients with diabetes poses many challenges in all …

Background: Glycemic outcomes during real-world hybrid closed-loop (HCL) system use by
individuals with type 1 diabetes, in the United States, were retrospectively analyzed …